/content/dam/www/people-profile-photos/r/mary-redman/mary-redman-d.jpg
Redman
Mary Redman, PhD

Mary Redman, PhD

  • Professor, Clinical Research Division, Fred Hutch

Background

Dr. Mary Redman is a biostatistician who specializes in complex studies, such as estimating the effects of treatments or environmental exposures that occur over many different points in time. She is especially interested in large-scale lung cancer treatment and prevention studies and works on them and other cancer trials as a statistician for SWOG, a National Cancer Institute–funded cooperative that conducts studies at 650 institutions across the U.S.

Lead Statistician, Lung Cancer Committee, Southwest Oncology Group (SWOG)

Lead Statistician, Lung-MAP

Education

PhD, Biostatistics, University of Washington, 2004

MS, Biostatistics, University of Washington, 2000

BS, Mathematics, University of Washington, 1997

Research Interests

Clinical trial design

Clinical trial design incorporating biomarkers

Find A Clinical Trial

Stories

All news
New protocols, precision approaches ahead for lung cancer Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients November 24, 2020
Numbers don’t lie, but sometimes our brains do Avoid confusion about statistics in medical research with these hints and resources February 13, 2020